DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Megace (Megestrol) - Mental Status Changes - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Mental Status Changes (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Megace (Megestrol) where reactions include mental status changes. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Megace side effects in 66 year old female

Reported by a physician from United States on 2012-03-23

Patient: 66 year old female, weighing 59.4 kg (130.7 pounds)

Reactions: Confusional State, Abdominal Pain, Vomiting, Mental Status Changes, Headache, Cognitive Disorder, Fatigue, Malaise

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lortab
    Dosage: every 6 hours as needed (5mg/500mg)
    Indication: Pain
    Start date: 2009-04-02
    End date: 2009-06-29

Megace
    Administration route: Oral
    Indication: Appetite Disorder

Radiation
    Dosage: qd 5 days a week, x 3weeks external beam 2d
    Start date: 2009-03-16
    End date: 2009-04-06

Colace
    Indication: Constipation
    Start date: 2009-04-02
    End date: 2009-08-28

Study Medication
    Dosage: wk1: 5 mg am,wk2: 5 mg am and 5 mg pm,wk3: 10mg am and 5 mg pm,wk4-24:10 mg am and 10 mg pm
    Indication: Prophylaxis
    Start date: 2009-05-12
    End date: 2009-07-07

Ranitidine
    Indication: Ulcer
    End date: 2009-08-28

Zofran
    Dosage: every 6 hours as needed
    Administration route: Oral
    Indication: Nausea
    End date: 2009-08-28

Simvastatin
    Indication: Blood Cholesterol
    Start date: 2009-02-27
    End date: 2009-08-28

Fergon
    Administration route: Oral
    Indication: Iron Deficiency
    Start date: 2009-02-27
    End date: 2009-08-28

Sunitinib Malate
    Indication: Renal Cancer
    Start date: 2009-06-01
    End date: 2009-08-28

Pioglitazone HCL
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-06-04

Other drugs received by patient: Artificial Tear; Aspirin; Actonel; Aspirin; Aspirin; Ciprofloxacin Hydrochloride; Extra Strength Tylenol



Possible Megace side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-22

Patient: 66 year old female, weighing 59.4 kg (130.7 pounds)

Reactions: Confusional State, Abdominal Pain, Vomiting, Blood Urea Increased, Nausea, Mental Status Changes, Cognitive Disorder, Headache, Pallor, Malaise, Fatigue, Posterior Reversible Encephalopathy Syndrome, Disturbance in Attention, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ferrous Gluconate (Ferrous Gluconate) Tablet
    Dosage: 325 mg, bid, oral
    Administration route: Oral
    Indication: Iron Deficiency
    Start date: 2009-02-27
    End date: 2009-08-28

Lortab
    Dosage: 1 df every 6 hours as needed
    Indication: Analgesic Therapy
    Start date: 2009-08-25
    End date: 2009-08-28

Lortab
    Dosage: 1 df every 6 hours as needed
    Indication: Analgesic Therapy
    Start date: 2009-04-02
    End date: 2009-06-29

Zofran
    Dosage: 1 df every 6 hours as needed, oral
    Administration route: Oral
    Indication: Nausea
    End date: 2009-08-28

Uncodeable ^unclassifiable^ (Uncodeable ^unclassifiable^)
    Dosage: qd 5 days a week x 3 weeks
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-03-16
    End date: 2009-04-06

Megace
    Dosage: 3 df, qd, oral
    Administration route: Oral
    Indication: Appetite Disorder

Simvastatin
    Dosage: 40 mg, bid
    Indication: Blood Cholesterol
    Start date: 2009-02-27
    End date: 2009-08-28

Sunitinib Malate
    Dosage: 50 mg, bid
    Indication: Renal Cancer
    Start date: 2009-06-01
    End date: 2009-08-28

Ranitidine
    Dosage: 150 mg, bid
    Indication: Ulcer
    End date: 2009-08-28

Pioglitazone
    Dosage: 30 mg, qd, oral
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-06-04

Uncodeable ^investigational Drug^ (Uncodeable ^investigational Drug^)
    Indication: Prophylaxis
    Start date: 2009-05-12
    End date: 2009-07-07

Colace (Docusate Sodium)
    Dosage: 100 mg, bid
    Indication: Constipation
    Start date: 2009-04-02
    End date: 2009-08-28

Other drugs received by patient: Artificial Tears; Aspirin; Actonel



Possible Megace side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-02

Patient: 66 year old female, weighing 59.4 kg (130.7 pounds)

Reactions: Abdominal Pain, Confusional State, Vomiting, Blood Urea Increased, Mental Status Changes, Cognitive Disorder, Headache, Malaise, Fatigue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zofran
    Dosage: 1 dosage forms, every 6 hrs, as needed, oral
    Administration route: Oral
    Indication: Nausea
    End date: 2009-08-28

Megace
    Dosage: daily, oral
    Administration route: Oral
    Indication: Decreased Appetite

Fergon
    Dosage: 325 mg, 2 in 1 d, oral
    Administration route: Oral
    Indication: Blood Iron Decreased
    Start date: 2009-02-27
    End date: 2009-08-28

Dutoglipitin (Investigational Drug)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-03-16
    End date: 2009-04-06

Colace (Docusate Sodium)
    Dosage: 100 mg, 2 in 1 d
    Indication: Constipation
    Start date: 2009-04-02
    End date: 2009-08-28

Lortab
    Dosage: 5 mg/500 mg every 6 hrs, as needed
    Indication: Analgesic Therapy
    Start date: 2009-04-02
    End date: 2009-08-28

Sunitinib Malate
    Dosage: 100 mg, 2 in 1 d
    Indication: Renal Cancer
    Start date: 2009-06-01
    End date: 2009-08-28

Pioglitazone Hydrochloride
    Dosage: 30 mg, oral
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-06-04

Ranitidine Hydrochloride
    Dosage: 300 mg
    Indication: Ulcer
    End date: 2009-08-28

Simvastatin
    Dosage: 40 mg, 2 in 1 d
    Indication: Blood Cholesterol Increased
    Start date: 2009-02-27
    End date: 2009-08-28

Other drugs received by patient: Artificial Tear (Hypromellose); Cipro; Actonel; Aspirin



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-21

Patient: female, weighing 59.4 kg (130.7 pounds)

Reactions: Confusional State, Abdominal Pain, Vomiting, Nausea, Mental Status Changes, Cognitive Disorder, Headache, Fatigue, Malaise

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carvedilol
    Dosage: 50 mg (25 mg, 2 in 1 d), unknown
    Indication: Product Used FOR Unknown Indication

Simvastatin
    Dosage: 80 mg (40 mg, 2 in 1 d) oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Sunitinib Malate
    Dosage: 100 mg (50 mg, 2 in 1 d) oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Tessalon
    Dosage: 300 mg (100 mg, 3 in 1 d), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Colace (Docusate Sodium)
    Dosage: 200 mg (100 mg, 2 in 1 d)
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 1 dosage forms, 6 hr, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Megace
    Dosage: oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Magnesium Citrate (Magnesium Citrate)
    Dosage: oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Fergon (Ferrous Gluconage)
    Dosage: 650 mg (325 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: Iron Deficiency

Lortab
    Dosage: 1 dosage forms 6 hr)
    Indication: Product Used FOR Unknown Indication

Pioglitazone Hydrochloride
    Dosage: 30 mg (30 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Amlodipine
    Dosage: 10 mg (10 mg, 1 in 1 d) oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ranitidine Hydrochloride
    Dosage: 300 mg (150 mg, 2 in 1 d)
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Extra Strength Tylenol; Aspirin; Cipro; Actonel; Artificial Tears (Hypromellose)

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017